116 related articles for article (PubMed ID: 7316467)
1. Differences in genetic stability between human cell lines from patients with and without lymphoreticular malignancy.
Povey S; Jeremiah S; Arthur E; Steel M; Klein G
Ann Hum Genet; 1980 Oct; 44(2):119-33. PubMed ID: 7316467
[TBL] [Abstract][Full Text] [Related]
2. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas.
Zech L; Haglund U; Nilsson K; Klein G
Int J Cancer; 1976 Jan; 17(1):47-56. PubMed ID: 946170
[TBL] [Abstract][Full Text] [Related]
3. Classification and biological nature of established human hematopoietic cell lines.
Nilsson K; Pontén J
Int J Cancer; 1975 Feb; 15(2):321-41. PubMed ID: 165156
[TBL] [Abstract][Full Text] [Related]
4. [Stereotyped chromosome abnormalities in human leukemia and lymphoma].
Berger R
Presse Med; 1983 Dec; 12(46):2937-41. PubMed ID: 6228876
[TBL] [Abstract][Full Text] [Related]
5. Isoenzyme studies in human leukemia-lymphoma cell lines--1. Carboxylic esterase.
Drexler HG; Gaedicke G; Minowada J
Leuk Res; 1985; 9(2):209-29. PubMed ID: 2985879
[TBL] [Abstract][Full Text] [Related]
6. Expression of cellular myc and mos genes in undifferentiated B cell lymphomas of Burkitt and non-Burkitt types.
Maguire RT; Robins TS; Thorgeirsson SS; Heilman CA
Proc Natl Acad Sci U S A; 1983 Apr; 80(7):1947-50. PubMed ID: 6300881
[TBL] [Abstract][Full Text] [Related]
7. No evidence for differences in the Epstein-Barr virus genome carried in Burkitt lymphoma cells and nonmalignant lymphoblastoid cells from the same patients.
Bornkamm GW; von Knebel-Doeberitz M; Lenoir GM
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4930-4. PubMed ID: 6087353
[TBL] [Abstract][Full Text] [Related]
8. The relation of oncogenesis and cytogenetics in leukemia and lymphoma.
Pearson M; Rowley JD
Annu Rev Med; 1985; 36():471-83. PubMed ID: 3888062
[TBL] [Abstract][Full Text] [Related]
9. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Steel CM; Morten JE; Foster E
IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993
[TBL] [Abstract][Full Text] [Related]
10. Application of cytogenetics in neoplastic diseases.
Sandberg AA
Crit Rev Clin Lab Sci; 1985; 22(3):219-74. PubMed ID: 3899509
[TBL] [Abstract][Full Text] [Related]
11. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias.
Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T
Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of malic enzyme: a possible marker for malignancy in lymphoid cells.
Povey S; Jeremiah S; Arthur E; Ber R; Fialkow PJ; Gardiner E; Goodfellow PN; Karande A; Klein G; Quintero M; Steel CM; Zeuthen J
Ann Hum Genet; 1981 Jul; 45(3):237-52. PubMed ID: 6946723
[TBL] [Abstract][Full Text] [Related]
13. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation.
Tsujimoto Y; Yunis J; Onorato-Showe L; Erikson J; Nowell PC; Croce CM
Science; 1984 Jun; 224(4656):1403-6. PubMed ID: 6610211
[TBL] [Abstract][Full Text] [Related]
15. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
16. Some questions on the significance of chromosome alterations in leukemias and lymphomas: a review.
Neri G
Am J Med Genet; 1984 Jul; 18(3):471-81. PubMed ID: 6383040
[TBL] [Abstract][Full Text] [Related]
17. Isoenzyme studies in human leukemia-lymphoma cells lines--II. Acid phosphatase.
Drexler HG; Gaedicke G; Minowada J
Leuk Res; 1985; 9(5):537-48. PubMed ID: 3874327
[TBL] [Abstract][Full Text] [Related]
18. Human tumors studied with genetic markers.
Fialkow PJ
Birth Defects Orig Artic Ser; 1976; 12(1):123-32. PubMed ID: 825156
[TBL] [Abstract][Full Text] [Related]
19. Biology and virology of the human malignant lymphomas: 1st Milford D. Schulz Lecture.
Kaplan HS; Goodenow RS; Gartner S; Bieber MM
Cancer; 1979 Jan; 43(1):1-24. PubMed ID: 83902
[TBL] [Abstract][Full Text] [Related]
20. BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability.
Brimmell M; Mendiola R; Mangion J; Packham G
Oncogene; 1998 Apr; 16(14):1803-12. PubMed ID: 9583678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
